The new tool helps it chase Reels and TikTok while marketers get more links to sponsored content.
Travelers handed much of their trip planning to AI chatbots this year, but the brands they book are often nowhere in the answers. Four in five of America's top 84 travel brands never appear in AI travel conversations, according to new research.
Shoppers have no shortage of loyalty cards, points, perks, and promises. What they lack is attachment to the brands doling them out.
fairlife leads protein-heavy brand rankings, while fiber brands and seasonal favorites show how variety and taste give GLP-1 users more reasons to buy.
Retention improved across industries, rewarding brands that tell stories rather than lead with sales pitches.
From fast delivery to free returns, first movers set costly new baselines for everyone.
Retailers can use purchase data and selective reminders to address hesitation without annoying customers.
Wider rollouts bring faster service but also range limits, noise complaints, and botched drops.
Adding names like Supergoop could build trust with new shoppers, but brands wary of its dupes may be hard to sign.
Its gambling label could curb ad spending for the category, especially if other ad networks follow suit.
The capability could strengthen discovery and agentic shopping—if Amazon can convince brands and retailers to share their data.
If new locations win deposits, banks that exited will have to fight their way back.
It's a pivot from in-chat checkout, sending tokenized card payments through merchants’ systems.
A big bank buyer could gain favorable interchange economics at smaller rivals’ expense.
A new Democratic Congress could deepen scrutiny into banks with the biggest gains.
New guidelines from the American Cancer Society aim to catch cancers earlier, but getting men screened remains a challenge.
Lower care costs through insurance will attract more patients to Maven, making transparency about what insurance does and doesn’t cover essential to setting clear expectations.
Pharma marketers need accurate drug information in AI answers to influence treatment discussions before visits.
Letting fans select their favorite leagues could give advertisers more precise targeting and sponsorship opportunities.
Faulty information can turn time-saving automation into costly rework, making verification essential.